N

    Nyxoah (NYXH)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $1.56
    -0.04 (-2.50%)

    Market Cap: $158.87M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    29%(6/21)
    Avg Surprise
    -5.51%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.33
    Range$-0.54 - $-0.20
    4 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.36-11.8%
    60d ago$-0.36-11.1%
    30d ago$-0.33-1.9%
    7d ago$-0.33-1.9%
    Current$-0.33
    Revenue Consensus
    $10M
    Range$9M - $10M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.00
    Range$-0.06 - $0.05
    3 analysts
    Revenue Consensus
    $14M
    Range$12M - $15M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.00---
    Sep 26EST
    		-$-0.33---
    Jun 26
    Reported Aug 5
    		$-0.67$-0.47-42.55%Miss-6.3%
    Mar 26
    Reported May 12
    		$-0.43$-0.63+31.64%Beat+28.1%
    Dec 25
    Reported Mar 19
    		$-0.59$-0.55-7.27%Miss-28.3%
    Sep 25
    Reported Nov 13
    		$-0.63$-0.56-12.50%Miss-26.0%
    Jun 25
    Reported Aug 18
    		$-0.63$-0.62-1.61%Miss-46.5%
    Mar 25
    Reported May 14
    		$-0.60$-0.51-16.60%Miss-46.3%
    Dec 24
    Reported Mar 13
    		$-0.46$-0.44-4.55%Miss-21.1%
    Sep 24
    Reported Nov 6
    		$-0.50$-0.45-11.11%Miss-85.2%
    Jun 24
    Reported Aug 6
    		$-0.43$-0.41-4.88%Miss+4.4%
    Mar 24
    Reported May 14
    		$-0.41$-0.41+0.00%Beat+10.9%
    Dec 23
    Reported Mar 5
    		$-0.38$-0.37-2.70%Miss+25.5%
    Sep 23
    Reported Nov 8
    		$-0.27$-0.43+37.21%Beat-12.5%
    Jun 23
    Reported Aug 8
    		$-0.45$-0.41-9.76%Miss-275.0%
    Mar 23
    Reported May 16
    		$-0.46$-0.34-35.29%Miss-76.9%
    Dec 22
    Reported Mar 22
    		$-0.51$-0.31-64.52%Miss-62.9%
    Sep 22
    Reported Nov 8
    		$-0.24$-0.33+27.27%Beat-1.2%
    Jun 22
    Reported Aug 8
    		$-0.12N/A+62.50%Beat+61.3%
    Mar 22
    Reported May 9
    		$-0.26$-0.33+21.21%Beat+15.6%
    Dec 21
    Reported Mar 24
    		$-0.31$-0.27-15.96%Miss-4.1%
    Sep 21
    Reported Nov 24
    		$-0.24$-0.23-3.13%Miss+7.2%
    Jun 21
    Reported Aug 31
    		$-0.31$-0.19-63.16%Miss-26.4%
    Mar 21
    Reported Apr 9
    		$-0.31$0.00N/AMiss-85.2%
    Dec 20
    Reported Mar 31
    		$-0.30$0.00N/AMiss-2325.0%
    Sep 20
    Reported Dec 31
    		$-0.26$0.00N/AMiss-2011.6%
    Jun 20
    Reported Aug 10
    		$-0.25$0.00N/AMiss-80.0%
    Dec 19
    Reported Mar 31
    		$-0.17$0.00N/AMiss-23.8%
    Sep 19
    Reported Dec 31
    		$-0.01$0.00N/AMiss-
    Jun 19
    Reported Sep 30
    		$-0.01$0.00N/AMiss-
    Mar 19
    Reported Jun 29
    		$-0.14$0.00N/AMiss-
    Dec 18
    Reported Mar 30
    		$-0.13$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.58EV/EBITDA-2.00x
    Price/FCF-1.04xFCF Yield-96.37%
    Profitability
    Profit Margin0.00%Operating Margin-268.30%
    ROE-122.70%ROIC-63.18%
    Financial Health
    Debt/Equity0.61xInterest Coverage-4.54x
    Current Ratio2.38xQuick Ratio2.31x
    Trading Statistics
    Beta0.95Avg Volume115.07K
    52-Week High$6.8752-Week Low$1.26

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.61
    SMA 20$1.56
    SMA 50$1.57
    SMA 200$3.26
    EMA 10$1.59
    EMA 20$1.58
    EMA 50$1.71
    EMA 200$3.18

    MACD

    Line: 0.01Signal: -0.00Hist: 0.01

    ADX

    ADX: 17.5+DI: 20.7-DI: 19.1

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down32.0
    PSAR$1.69

    Bollinger Bands

    Upper Band$1.74
    Lower Band$1.39
    %B Position2234%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    47.3

    Momentum Oscillators

    Stoch %K29.2
    Stoch %D48.7
    Williams %R-87.1
    ROC (10d)-2.5%
    Momentum-0.04
    CCI (20d)10.2
    MFI (14d)51.9

    Volatility Measures

    ATR (14d)$0.08(4.9%)
    StdDev (20d)0.09
    Hist Vol64.0%(High)

    Volume Flow

    VWAP$1.58
    OBV-7.1M
    AD Line-12.9M
    CMF (20d)-0.106

    Volume Metrics

    Avg Vol (20d)116.5K
    Vol Ratio0.9x
    VWMA (20d)$1.55

    Pivot Points

    R3$1.69
    R2$1.66
    R1$1.63
    Pivot Point$1.60
    S1$1.57
    S2$1.54
    S3$1.51

    Advanced Oscillators

    TSI2.13
    Ultimate Osc34.2
    KST54.09

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$7.67M$7.36M$5.64M$1.97M$1.34M$1.06M$1.26M$1.27M$771,000$1.22M$1.82M$976,000
    Cost of Revenue$3.09M$5.14M$2.02M$779,000$490,000$406,000$335,000$482,000$281,000$455,000$726,000$336,000
    Gross Profit$4.58M$2.22M$3.63M$1.19M$850,000$658,000$928,000$784,000$490,000$766,000$1.10M$640,000
    Operating Expenses$25.17M$25.95M$21.88M$25.39M$20.70M$21.30M$19.24M$15.76M$13.80M$12.98M$11.94M$11.63M
    R&D$9.54M$8.70M$10.87M$12.91M$10.08M$9.02M$11.79M$7.93M$7.56M$7.13M$8.33M$7.06M
    SG&A$15.62M$14.94M$11.98M$12.12M$10.32M$12.03M$7.70M$7.71M$6.07M$5.70M$4.59M$4.80M
    Operating Income$-20,588,000$-23,731,299$-18,259,000$-24,195,000$-19,850,000$-20,639,000$-18,311,000$-14,980,000$-13,307,000$-12,213,000$-10,837,000$-10,986,000
    Interest Income$82,000$168,000$129,000$247,000$513,000$945,000$829,000$703,000$2.07M$498,000$756,000$831,000
    Interest Expense$13.08M$1.36M$3.36M$700,000$677,000$694,000$1.36M$672,000$352,000$107,900$51,875$68,710
    Income Before Tax$-32,487,000$-17,970,624$-22,618,000$-23,870,000$-20,329,000$-22,259,000$-15,069,000$-16,885,000$-12,683,000$-11,796,000$-11,219,000$-9,841,000
    Income Tax Expense$477,000$450,594$895,000$-290,000$278,000$125,000$2.08M$173,000$441,000$110,000$-326,000$-2,229,000
    Net Income$-32,964,000$-18,421,219$-23,513,000$-23,580,000$-20,607,000$-22,384,000$-17,149,000$-17,058,000$-13,124,000$-11,906,000$-10,893,000$-7,612,000
    EBITDA$-19,409,000$-14,629,295$-21,502,000$-21,730,000$-19,296,000$-21,202,000$-14,814,000$-15,879,000$-11,671,000$-10,827,000$-10,448,000$-9,009,000
    EBITN/A$-16,611,909$-22,998,000$-23,170,000$-19,652,000$-21,565,000$-15,568,000$-16,213,000$-12,331,000$-11,437,000$-11,172,000$-9,528,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NYXH

    News

    Nyxoah Updates Share Count and Potential Dilution From Convertible Instruments

    Nyxoah SA has announced an update to its capital structure, issuing 1.8 million new shares related to convertible bonds, which increases its total voting shares to approximately 101.8 million. The company also disclosed potential future dilution from outstanding subscription rights and additional convertible bonds, which could collectively add up to 13.4 million voting rights. Stakeholders are advised to monitor these instruments as they could impact Nyxoah's ownership and voting structure.

    TipRanks•8/29/26•
    Somewhat-Bearish

    Information on the total number of voting rights and shares

    Nyxoah SA has issued a regulatory announcement regarding its total number of voting rights and shares following the issuance of 1,767,402 new shares on August 20, 2026. This issuance was related to a contribution in kind from the holder of convertible bonds. The company details its current share capital, total voting rights, unissued subscription rights, and potential voting rights upon conversion of outstanding convertible bonds.

    Yahoo Finance Singapore•8/25/26•
    Neutral

    Information on the total number of voting rights and shares

    Nyxoah SA has published updated information regarding its total voting rights and shares, following the issuance of 1,767,402 new shares on August 20, 2026. This transaction was related to a contribution in kind from a convertible bondholder. The company detailed its share capital, total voting rights, unissued subscription rights, and potential voting rights from convertible bonds under different conversion scenarios.

    GlobeNewswire•8/25/26•
    Neutral

    Cantor Fitzgerald cuts Nyxoah stock price target on valuation

    Cantor Fitzgerald has lowered its price target on Nyxoah SA to $6.00 from $11.00, while maintaining an Overweight rating, despite the stock currently trading significantly lower at $1.62. The adjustment reflects current trading levels, even though Nyxoah has shown strong operational growth with 89 new accounts activated and 55 new surgeons added in Q2 2026, leading to a 339% revenue surge in the last twelve months. However, the company is still unprofitable and burning cash quickly, contributing to investor caution despite recent positive revenue reports.

    Investing.com•8/17/26•
    Somewhat-Bearish

    Cantor Fitzgerald Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price

    Cantor Fitzgerald has lowered its price target for Nyxoah (NASDAQ:NYXH) to $6.00 but maintains an "overweight" rating, suggesting a significant upside despite the pessimistic forecast. Other analysts have issued mixed ratings, with a consensus "Hold" and an average price target of $4.26. Nyxoah recently reported a quarterly loss of $0.67 per share, missing estimates, although revenue exceeded expectations.

    MarketBeat•8/17/26•
    Bearish

    Frequently Asked Questions About NYXH

    Does NYXH pay dividends?
    Nyxoah (NYXH) does not currently pay a regular dividend.
    What is NYXH's market cap?
    Nyxoah (NYXH) has a market capitalization of $158.87M with a current stock price of $1.56.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In